SM

Sandra Medina-Moreno

Institute of Human Virology, University of Maryland

Affiliated withUniversity of Maryland

Research Area

Immunology and Infection

Biography

Sandra Medina-Moreno has not added Biography.
If you are Sandra Medina-Moreno and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 4	2019

Other Publications

Article	Year
Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and prot... Journal of virology\| PubMed ID: 12692223	2003
A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali. The American journal of tropical medicine and hygiene\| PubMed ID: 16014826	2005
Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous pri... Infection and immunity\| PubMed ID: 17502396	2007
Impact of horizontal approach in vertical program: continuous quality improvement of malaria and tuberculosis diagnostic services at primary-level medical laboratories in the context of HIV ... The American journal of tropical medicine and hygiene\| PubMed ID: 23324221	2013
Indirubin 3'-monoxime, from a Chinese traditional herbal formula, suppresses viremia in humanized mice infected with multidrug-resistant HIV. AIDS research and human retroviruses\| PubMed ID: 24401082	2014
Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo Studies. AIDS research and human retroviruses\| PubMed ID: 26059995	2016
Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 26170311	2015
Active Tuberculosis Case Finding in Port-au-Prince, Haiti: Experiences, Results, and Implications for Tuberculosis Control Programs. Tuberculosis research and treatment\| PubMed ID: 27668093	2016
Monotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized mice. The Journal of antimicrobial chemotherapy\| PubMed ID: 28637235	2017
Targeting of CDK9 with indirubin 3'-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice. PloS one\| PubMed ID: 28817720	2017
Diagnostics for Lassa Fever: Detecting Host Antibody Responses. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 28986826	2018
A Primate Model for Viral Hemorrhagic Fever. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 28986843	2018
Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings. PloS one\| PubMed ID: 30192818	2018
Improving the Breadth of the Host's Immune Response to Lassa Virus. Pathogens (Basel, Switzerland)\| PubMed ID: 30373278	2018
Disparate effects of cytotoxic chemotherapy on the antiviral activity of antiretroviral therapy: implications for treatments of HIV-infected cancer patients. Antiviral therapy\| PubMed ID: 30574873	2019
T-Cell Response to Viral Hemorrhagic Fevers. Vaccines\| PubMed ID: 30678246	2019
HIV Replication in Humanized IL-3/GM-CSF-Transgenic NOG Mice. Pathogens (Basel, Switzerland)\| PubMed ID: 30871027	2019
Suppression of Active HIV-1 Infection in CD34 Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs. AIDS research and human retroviruses\| PubMed ID: 31099257	2019
A Single Dose of Modified Vaccinia Ankara Expressing Lassa Virus-like Particles Protects Mice from Lethal Intra-cerebral Virus Challenge. Pathogens (Basel, Switzerland)\| PubMed ID: 31466243	2019

Copyright © 2026 MyJoVE Corporation. All rights reserved.